Over the past year the Biden Administration through two Executive Orders (EO) and a guide from the Food and Drug Administration (FDA) has been pushing Enterprise Risk Management (ERM). This piece looks at this trend and some of its implications.

Executive Order M-22-04

On December 3, 2021, Executive Order M-22-04 was issued. The subject was “Promoting Accountability through Cooperation among Agencies and Inspector Generals (IG)”. This EO is geared towards improving cooperation between the agencies and their Inspector Generals. The EO states: Continue reading →